These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 33489469)

  • 1. Immunological alternation in COVID-19 patients with cancer and its implications on mortality.
    Cai G; Gao Y; Zeng S; Yu Y; Liu X; Liu D; Wang Y; Yu R; Desai A; Li C; Gao Q
    Oncoimmunology; 2021 Jan; 10(1):1854424. PubMed ID: 33489469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk Factors for Mortality of COVID-19 Patient Based on Clinical Course: A Single Center Retrospective Case-Control Study.
    Zhang J; Wang Z; Wang X; Hu Z; Yang C; Lei P
    Front Immunol; 2021; 12():581469. PubMed ID: 33664741
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical characteristics and peripheral immunocyte subsets alteration of 85 COVID-19 deaths.
    Xiong L; Zang X; Feng G; Zhao F; Wang S; Zeng W; Yu K; Zhai Y
    Aging (Albany NY); 2021 Mar; 13(5):6289-6297. PubMed ID: 33711813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological Characteristics in Type 2 Diabetes Mellitus Among COVID-19 Patients.
    Han M; Ma K; Wang X; Yan W; Wang H; You J; Wang Q; Chen H; Guo W; Chen T; Ning Q; Luo X
    Front Endocrinol (Lausanne); 2021; 12():596518. PubMed ID: 33776910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated Exhaustion Levels of NK and CD8
    Li M; Guo W; Dong Y; Wang X; Dai D; Liu X; Wu Y; Li M; Zhang W; Zhou H; Zhang Z; Lin L; Kang Z; Yu T; Tian C; Qin R; Gui Y; Jiang F; Fan H; Heissmeyer V; Sarapultsev A; Wang L; Luo S; Hu D
    Front Immunol; 2020; 11():580237. PubMed ID: 33154753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphocyte may be a reference index of the outcome of cancer patients with COVID-19.
    Zhang W; Gao Y; Hu G; Chu Q; Yuan X
    Aging (Albany NY); 2021 Mar; 13(6):7733-7744. PubMed ID: 33735106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association Between Average Plasma Potassium Levels and 30-day Mortality During Hospitalization in Patients with COVID-19 in Wuhan, China.
    Liu S; Zhang L; Weng H; Yang F; Jin H; Fan F; Zheng X; Yang H; Li H; Zhang Y; Li J
    Int J Med Sci; 2021; 18(3):736-743. PubMed ID: 33437208
    [No Abstract]   [Full Text] [Related]  

  • 8. Pregnant women with SARS-CoV-2 infection are at higher risk of death and pneumonia: propensity score matched analysis of a nationwide prospective cohort (COV19Mx).
    Martinez-Portilla RJ; Sotiriadis A; Chatzakis C; Torres-Torres J; Espino Y Sosa S; Sandoval-Mandujano K; Castro-Bernabe DA; Medina-Jimenez V; Monarrez-Martin JC; Figueras F; Poon LC
    Ultrasound Obstet Gynecol; 2021 Feb; 57(2):224-231. PubMed ID: 33320401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood Interferon-α Levels and Severity, Outcomes, and Inflammatory Profiles in Hospitalized COVID-19 Patients.
    Contoli M; Papi A; Tomassetti L; Rizzo P; Vieceli Dalla Sega F; Fortini F; Torsani F; Morandi L; Ronzoni L; Zucchetti O; Pavasini R; Fogagnolo A; Volta CA; Bartlett NW; Johnston SL; Spadaro S; Campo G
    Front Immunol; 2021; 12():648004. PubMed ID: 33767713
    [No Abstract]   [Full Text] [Related]  

  • 10. Mild Cytokine Elevation, Moderate CD4
    Jia R; Wang X; Liu P; Liang X; Ge Y; Tian H; Chang H; Zhou H; Zeng M; Xu J
    Virol Sin; 2020 Dec; 35(6):734-743. PubMed ID: 32699972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intestinal Host Response to SARS-CoV-2 Infection and COVID-19 Outcomes in Patients With Gastrointestinal Symptoms.
    Livanos AE; Jha D; Cossarini F; Gonzalez-Reiche AS; Tokuyama M; Aydillo T; Parigi TL; Ladinsky MS; Ramos I; Dunleavy K; Lee B; Dixon RE; Chen ST; Martinez-Delgado G; Nagula S; Bruce EA; Ko HM; Glicksberg BS; Nadkarni G; Pujadas E; Reidy J; Naymagon S; Grinspan A; Ahmad J; Tankelevich M; Bram Y; Gordon R; Sharma K; Houldsworth J; Britton GJ; Chen-Liaw A; Spindler MP; Plitt T; Wang P; Cerutti A; Faith JJ; Colombel JF; Kenigsberg E; Argmann C; Merad M; Gnjatic S; Harpaz N; Danese S; Cordon-Cardo C; Rahman A; Schwartz RE; Kumta NA; Aghemo A; Bjorkman PJ; Petralia F; van Bakel H; Garcia-Sastre A; Mehandru S
    Gastroenterology; 2021 Jun; 160(7):2435-2450.e34. PubMed ID: 33676971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral immunological features of COVID-19 patients in Taizhou, China: A retrospective study.
    Jin XH; Zhou HL; Chen LL; Wang GF; Han QY; Zhang JG; Zhang X; Chen QY; Ye YH; Lin A; Yan WH
    Clin Immunol; 2021 Jan; 222():108642. PubMed ID: 33253854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of immune cells and cytokines in patients with coronavirus disease 2019 in Guangzhou, China.
    Chen X; Huang J; Huang Y; Chen J; Huang Y; Jiang X; Shi Y
    Hum Immunol; 2020 Dec; 81(12):702-708. PubMed ID: 32950268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of blood analysis and immune function on the prognosis of patients with COVID-19.
    Fu YQ; Sun YL; Lu SW; Yang Y; Wang Y; Xu F
    PLoS One; 2020; 15(10):e0240751. PubMed ID: 33125396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with acute cardiac injury and their effects on mortality in patients with COVID-19.
    He X; Wang L; Wang H; Xie Y; Yu Y; Sun J; Yan J; Du Y; Shen Y; Zeng H
    Sci Rep; 2020 Nov; 10(1):20452. PubMed ID: 33235220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study.
    Yang K; Sheng Y; Huang C; Jin Y; Xiong N; Jiang K; Lu H; Liu J; Yang J; Dong Y; Pan D; Shu C; Li J; Wei J; Huang Y; Peng L; Wu M; Zhang R; Wu B; Li Y; Cai L; Li G; Zhang T; Wu G
    Lancet Oncol; 2020 Jul; 21(7):904-913. PubMed ID: 32479787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical presentation and course of the novel coronavirus disease 2019 in patients with various types of cancer: A retrospective case-control analysis of an experienced cancer center in Turkey.
    Acar R; Yilmaz G; Savasci U; Aykan MB; Kiziloz H; Cuce F; Kadioglu E; Filiz M; Fidan G; Eksert S; Taskin G; Dogan D; Arslan Y; Tasci C; Kayahan N; Dogan T; Basgoz BB; Sertoglu E; Erturk I; Keskin GSY; Okcelik S; Yildiz B; Karadurmus N
    J Cancer Res Ther; 2021; 17(2):556-564. PubMed ID: 34121708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunosuppression as a Hallmark of Critical COVID-19: Prospective Study.
    Kalicińska E; Szymczak D; Zińczuk A; Adamik B; Smiechowicz J; Skalec T; Nowicka-Suszko D; Biernat M; Bogucka-Fedorczuk A; Rybka J; Martuszewski A; Gozdzik W; Simon K; Wróbel T
    Cells; 2021 May; 10(6):. PubMed ID: 34071149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interpretation of Hematological, Biochemical, and Immunological Findings of COVID-19 Disease: Biomarkers Associated with Severity and Mortality.
    Ghazanfari T; Salehi MR; Namaki S; Arabkheradmand J; Rostamian A; Rajabnia Chenary M; Ghaffarpour S; Kaboudanian Ardestani S; Edalatifard M; Naghizadeh MM; Mohammadi S; Mahloujirad M; Izadi A; Ghanaati H; Beigmohammadi MT; Vodjgani M; Mohammad Shirazi B; Mirsharif ES; Abdollahi A; Mohammadi M; Emadi Kouchak H; Dehghan Manshadi SA; Zamani MS; Mahmoodi Aliabadi M; Jamali D; Khajavirad N; Mohseni Majd AM; Nasiri Z; Faghihzadeh S
    Iran J Allergy Asthma Immunol; 2021 Feb; 20(1):46-66. PubMed ID: 33639632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum Interleukin-6 Concentrations and the Severity of COVID-19 Pneumonia: A Retrospective Study at a Single Center in Bengbu City, Anhui Province, China, in January and February 2020.
    Sun H; Guo P; Zhang L; Wang F
    Med Sci Monit; 2020 Nov; 26():e926941. PubMed ID: 33175722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.